Literature DB >> 8940906

Differential assembly of cytoskeletal and sarcomeric actins in developing skeletal muscle cells in vitro.

K Hayakawa1, S Ono, R Nagaoka, O Saitoh, T Obinata.   

Abstract

Monoclonal antibodies (McAb) to actin were prepared to analyze the assembly of actin isoforms in developing muscle cells in vitro. One of the antibodies (SkA-06) was specific for alpha-sarcomeric actin isoforms in skeletal and cardiac muscles, while the others recognized cytoskeletal (beta, gamma) actin isoforms in smooth muscle and non-muscle tissues as well as the sarcomeric (alpha) actins. Using SkA-06 and a polyclonal antibody (PcAb) specific for cytoskeletal actins, the subcellular localization of the actin isoforms was examined by immunocytochemical methods. While in developing young myotubes, cytoskeletal and sarcomeric actins were co-localized in nascent myofibrils or stress-fiber-like structures, sarcomeric actins predominated in striated myofibrils in more developed myotubes. When FITC-labeled cytoskeletal and sarcomeric actins were introduced into young myotubes by a microinjection method, the latter became detectable in striated structures sooner than the former but they were finally incorporated into striated myofibrils. These results suggest that alpha-actin(s) as well as beta- and gamma-actins can be incorporated into myofibrils, but alpha-actin(s) is assembled preferentially into myofibrils in developing muscle cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940906     DOI: 10.2108/zsj.13.509

Source DB:  PubMed          Journal:  Zoolog Sci        ISSN: 0289-0003            Impact factor:   0.931


  10 in total

1.  A micropatterning approach for imaging dynamic Cx43 trafficking to cell-cell borders.

Authors:  Shan-Shan Zhang; SoonGweon Hong; André G Kléber; Luke P Lee; Robin M Shaw
Journal:  FEBS Lett       Date:  2014-01-17       Impact factor: 4.124

2.  Quantitative analysis of low molecular weight G-actin-binding proteins, cofilin, ADF and profilin, expressed in developing and degenerating chicken skeletal muscles.

Authors:  R Nagaoka; N Minami; K Hayakawa; H Abe; T Obinata
Journal:  J Muscle Res Cell Motil       Date:  1996-08       Impact factor: 2.698

3.  GJA1-20k Arranges Actin to Guide Cx43 Delivery to Cardiac Intercalated Discs.

Authors:  Wassim A Basheer; Shaohua Xiao; Irina Epifantseva; Ying Fu; Andre G Kleber; TingTing Hong; Robin M Shaw
Journal:  Circ Res       Date:  2017-09-18       Impact factor: 17.367

4.  Actin cytoskeleton rest stops regulate anterograde traffic of connexin 43 vesicles to the plasma membrane.

Authors:  James W Smyth; Jacob M Vogan; Pranali J Buch; Shan-Shan Zhang; Tina S Fong; Ting-Ting Hong; Robin M Shaw
Journal:  Circ Res       Date:  2012-02-09       Impact factor: 17.367

5.  Activity of cofilin can be regulated by a mechanism other than phosphorylation/dephosphorylation in muscle cells in culture.

Authors:  Atsuko Hosoda; Naruki Sato; Rie Nagaoka; Hiroshi Abe; Takashi Obinata
Journal:  J Muscle Res Cell Motil       Date:  2007-09-07       Impact factor: 2.698

Review 6.  Trafficking highways to the intercalated disc: new insights unlocking the specificity of connexin 43 localization.

Authors:  Shan-Shan Zhang; Robin M Shaw
Journal:  Cell Commun Adhes       Date:  2014-02

Review 7.  Dynamic regulation of sarcomeric actin filaments in striated muscle.

Authors:  Shoichiro Ono
Journal:  Cytoskeleton (Hoboken)       Date:  2010-11

8.  Generation of functional beta-actinin (CapZ) in an E. coli expression system.

Authors:  Y Soeno; H Abe; S Kimura; K Maruyama; T Obinata
Journal:  J Muscle Res Cell Motil       Date:  1998-08       Impact factor: 2.698

Review 9.  Intracellular trafficking pathways of Cx43 gap junction channels.

Authors:  Irina Epifantseva; Robin M Shaw
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-05-30       Impact factor: 3.747

10.  A method for rapidly screening functionality of actin mutants and tagged actins.

Authors:  Heidi Rommelaere; Davy Waterschoot; Katrien Neirynck; Joël Vandekerckhove; Christophe Ampe
Journal:  Biol Proced Online       Date:  2004-10-25       Impact factor: 3.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.